Christopher Peetz
2019
In 2019, Christopher Peetz earned a total compensation of $6.2M as Chief Executive Officer and President at Mirum Pharmaceuticals.
Compensation breakdown
| Bonus | $286,100 |
|---|---|
| Option Awards | $5,491,471 |
| Salary | $457,614 |
| Total | $6,235,185 |
Peetz received $5.5M in option awards, accounting for 88% of the total pay in 2019.
Peetz also received $286.1K in bonus and $457.6K in salary.
Rankings
In 2019, Christopher Peetz's compensation ranked 1,605th out of 13,971 executives tracked by ExecPay. In other words, Peetz earned more than 88.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,605 out of 13,971 | 89th |
Division Manufacturing | 576 out of 5,701 | 90th |
Major group Chemicals And Allied Products | 172 out of 2,200 | 92nd |
Industry group Drugs | 138 out of 1,886 | 93rd |
Industry Pharmaceutical Preparations | 104 out of 1,398 | 93rd |
Source: SEC filing on April 14, 2021.
News
Mirum Pharmaceuticals CEO Christopher Peetz's 2023 pay jumps 47% to $6.5M
April 23, 2024
Mirum Pharmaceuticals CEO Christopher Peetz's 2022 pay rises 7% to $4.4M
May 1, 2023
Mirum Pharmaceuticals CEO Christopher Peetz's 2021 pay jumps 38% to $4.1M
April 22, 2022
Mirum Pharmaceuticals CEO Christopher Peetz's 2020 pay falls 52% to $3M
April 14, 2021